PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 28, 2024Clinical Cancer Research10 citations

A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma

View Full Paper

Authors

ECElaine ChangJZJiaxi ZhouCSChi Song

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Chang et al. (2024) studied this question.

synapsesocial.com/papers/68e7720db6db6435876e70dahttps://doi.org/10.1158/1078-0432.ccr-23-3719
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Data from A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma2024
  2. 2Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 2142024 · 23 citations
  3. 3Real-world outcomes among patients with advanced/metastatic renal cell carcinoma (mRCC) treated with tyrosine kinase inhibitors (TKls) monotherapy or TKI-IO combination therapy.2024
  4. 4Supplementary Figure S2 from A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma2024
  5. 5Supplementary Figure S2 from A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma2024